247 results on '"Scheule, Ronald K."'
Search Results
52. Systemic Insulin-like Growth Factor-1 Reverses Hypoalgesia and Improves Mobility in a Mouse Model of Diabetic Peripheral Neuropathy
53. Ability of Adeno-Associated Virus Serotype 8-Mediated Hepatic Expression of Acid α-Glucosidase to Correct the Biochemical and Motor Function Deficits of Presymptomatic and Symptomatic Pompe Mice
54. Timing of Therapeutic Intervention Determines Functional and Survival Outcomes in a Mouse Model of Late Infantile Batten Disease
55. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo
56. 217. Comparison of Hepatic Vein and Peripheral Vein Delivery of an AAV2/8 Vector Encoding Human a-Galactosidase A to Rhesus Macaques
57. 893. Second Generation Gene Therapy Vector for Classical Late Infantile Neuronal Ceroid Lipofuscinosis
58. 695. Low-Frequency Ultrasound Increases Non- Viral Lung Gene Transfer
59. Gene therapy for lung cancer - an application for cationic lipid-mediated gene delivery?
60. Local Delivery of a Viral Vector Mitigates Neutralization by Antiviral Antibodies and Results in Efficient Transduction of Rabbit Liver
61. Transient siRNA-Mediated Attenuation of Liver Expression from an α-Galactosidase a Plasmid Reduces Subsequent Humoral Immune Responses to the Transgene Product in Mice
62. Long-term Transgene Expression from Plasmid DNA Gene Therapy Vectors Is Negatively Affected by CpG Dinucleotides
63. Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors
64. Partial correction of the α‐galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors
65. Hydrodynamic delivery of DNA
66. DNA Sequences in Cationic Lipid:pDNA-Mediated Systemic Toxicities
67. Development of Catheter-Based Procedures for Transducing the Isolated Rabbit Liver with Plasmid DNA
68. Tumor Treatment with Complexes of Cationic Lipid and Noncoding Plasmid DNA Results in the Induction of Cytotoxic T Cells and Systemic Tumor Elimination
69. CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in Vivo
70. Cationic Liposome-Mediated Gene Delivery to the Liver and to Hepatocellular Carcinomas in Mice
71. Comprehensive Analysis of the Acute Toxicities Induced by Systemic Administration of Cationic Lipid:Plasmid DNA Complexes in Mice
72. TOXICITY OF CATIONIC LIPOSOME-DNA COMPLEX IN LUNG ISOGRAFTS
73. Cationic Lipid Structure and Formulation Considerations for Optimal Gene Transfection of the Lung
74. Contribution of Plasmid DNA to Inflammation in the Lung after Administration of Cationic Lipid:pDNA Complexes
75. Liposome-mediated gene transfer in rat lung transplantation: A comparison between the in vivo and ex vivo approaches
76. Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression
77. Aerosolization of Cationic Lipid:pDNA Complexes—In Vitro Optimization of Nebulizer Parameters for Human Clinical Studies
78. A Concentrated and Stable Aerosol Formulation of Cationic Lipid:DNA Complexes Giving High-Level Gene Expression in Mouse Lung
79. Basis of Pulmonary Toxicity Associated with Cationic Lipid-Mediated Gene Transfer to the Mammalian Lung
80. Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the Lung
81. Purification and Characterization of Recombinant Cystic Fibrosis Transmembrane Conductance Regulator from Chinese Hamster Ovary and Insect Cells
82. Repeated nebulisation of non-viral CFTRgene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
83. The in vivo effects of rhIL-lα therapy on human monocyte activity
84. Effects of continuous high dose rhgm‐csf infusion on human monocyte activity
85. Human Alveolar Macrophage Cytokine Release in Response to in Vitro and in Vivo Asbestos Exposure
86. Detection of CFTR transgene mRNA expression in respiratory epithelium isolated from the murine nasal cavity.
87. Lung lining fluid modification of asbestos bioactivity for the alveolar macrophage
88. In VitroBioactivity of Asbestos for the Human Alveolar Macrophage and its Modification by IgG
89. Immunologic Aspects of Pneumoconiosis
90. Surfactant Protein-D and Surfactant Inhibit Endotoxin-Induced Pulmonary lnflammation.
91. Alveolar Macrophage Biology
92. Role of extracellular calcium in chrysotile asbestos stimulation of alveolar macrophages
93. Section 2: CATIONIC LIPOSOMES Chapter 7: Toxicity of Cationic Lipid-DNA Complexes.
94. Partial correction of the α-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors.
95. Bleomycin stimulation of cytokine secretion by the human alveolar macrophage.
96. Transforming growth factor–ß1 gene transfer ameliorates acute lung allograft rejection
97. Aerosolization of Cationic Lipid:pDNA ComplexesIn VitroOptimization of Nebulizer Parameters for Human Clinical Studies
98. Optimization of Formulations and Conditions for the Aerosol Delivery of Functional Cationic Lipid:DNA Complexes
99. Novel preparation of functional Sindbis virosomes
100. Reconstitution of membranes with fractions of triton X-100 which are easily removed
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.